[A randomized trial of intensive versus standard blood pressure control].

By J. D. Divisón Garrote, C. Escobar Cervantes. 2016

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Medical & Health AI

Citations in the corpus

Privacy-Preserving Generative Deep Neural Networks Support Clinical Data Sharing (2017, methodology): “We evaluated usefulness by: (1) comparing variable distributions between the real and simulated data, (2) comparing the correlation structure between variables in the real and simulated data, (3) comparing machine learning predictors constructed on real vs.”
Explainable AI for Trees: From Local Explanations to Global Understanding (2019, background): “For the mortality model a SHAP dependence plot reproduces the standard risk inflection point known for systolic blood pressure between 120 mmHg and 140 mmHg [23] (Figure 4B).”
Measurement of Blood Pressure in Humans (2019, methodology): “For patients with established hypertension taking antihypertensive medication, the 2017 Hypertension Clinical Practice Guidelines recommend having patients return at approximately monthly intervals after initiating/titrating antihypertensive medication until their goal BP is reached.1 This aligns wi”
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019) (2019, methodology): “from the SPRINT trial comparing two targets of blood pressure control (SBP: <120 mmHg and <140 mmHg) [92, 1294] is important.”
Gut microbiota dysbiosis contributes to the development of hypertension (2017, result): “Moreover, our findings fully support the updated conclusion by the Systolic Blood Pressure Intervention Trial (SPRINT) research group, that controlling one’s SBP to an optimal level lower than 120 mmHg rather than a pHTN level below 140 mmHg leads to significantly decreased occurrence of cardiovascu”
Global vascular guidelines on the management of chronic limb-threatening ischemia (2019, background): “However, intensive blood pressure control may result in greater morbidity associated with periods of clinically significant hypotension.(45,47) Optimal blood pressure control for patients with CLTI has not been established, and although maintaining systolic pressure <140 mmHg and diastolic pressure ”
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. (2017, background): “In elderly, frail patients, the target can be more lenient, whereas in patients at very high risk who tolerate multiple blood pressurelowering drugs, a target of < 120 mmHg may be considered.(4,315,316) Despite the proven efficacy of this treatment, non-adherence to lifestyle interventions and medic”
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. (2017, unknown): “A large RCT demonstrated that in those with increased cardiovascular risk (defined as age >75 years, established vascular disease, chronic renal disease, or a Framingham Risk Score >15%), control of blood pressure to a goal systolic pressure of <120 mm Hg, as determined by blood pressure assessment ”